Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 133,498 shares at $25.36 ($3.4M) on 2023-03-31, disclosed to the SEC on 2023-03-31.
Open-market sale of $3.4M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 38,498 | $1.0M | 29.4% |
| 2 | $25.36 | 95,000 | $2.4M | 70.6% |
| Total | $25.54 avg | 133,498 | $3.4M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |